Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
GWPH
GW Pharmaceuticals Plc ADS
259
Follow
259
GWPH
GW Pharmaceuticals Plc ADS
259
Follow
259
Likes Subject
Older
https://www.benzinga.com/news/earnings/21/11/24060763/you-ask-we-analyze-why-sun BottomBounce 11/16/21 11:02 AM
Interesting comparison......I did the same thing with GWPH Magnum7419 07/01/21 12:34 PM
$GWPH https://newrepublic.com/article/162594/marijuana-legalization-dc-biden-har BottomBounce 06/17/21 2:04 PM
Better Buy: Medical Marijuana vs. GW Pharmaceuticals BottomBounce 06/10/21 11:25 AM
got them yesterday john1311 05/12/21 10:46 AM
Anyone have any idea of when the Jazz lesgetrich 05/06/21 10:56 AM
$gwph 215.25 ^ 0.1 (0.05%) Taurus69 03/20/21 8:33 PM
These stocks just keep going up and down @realToothFairy 02/26/21 9:52 PM
$gwph $213.81 ^ 0.89 (0.42%) Taurus69 02/19/21 7:00 PM
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End john1311 02/16/21 7:14 AM
Gwph and Rbii. Looks the same SkyPilotUSA 02/11/21 9:03 AM
Better Buy: Medical Marijuana vs. GW Pharmaceuticals BottomBounce 02/05/21 11:08 AM
Congratulations to the longs of all longs!!! Panzer 02/04/21 2:08 AM
I will and I will add. This Tanis2476 02/03/21 7:41 PM
Didn't see this coming. Had a limit nunaka 02/03/21 6:28 PM
Boom! What a great day Cosa 02/03/21 1:00 PM
This is worth at least 20 billion easily Sooo Waht 02/03/21 11:09 AM
This is great news we held and were longboarder7892 02/03/21 10:24 AM
Congrats all Longs! Now let’s see if another Tanis2476 02/03/21 9:27 AM
HALTED. GETTING BOUGHT. 220 adr mkendra 02/03/21 7:56 AM
$gwph $152.47 ^ 4.47 (3.02%) Taurus69 01/30/21 7:29 PM
Better Buy: Medical Marijuana vs. GW Pharmaceuticals BottomBounce 01/16/21 8:27 AM
GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year john1311 01/11/21 7:38 AM
$gwph $116.25 ^ 1.04 (0.90%) Taurus69 01/05/21 10:53 PM
$gwph $120.43 v -3.83 (-3.08%) Taurus69 12/12/20 6:52 PM
What’s looking good? This has been a lame @realToothFairy 12/10/20 5:12 PM
Still looking great! Good luck everyone $GWPH Cbdpotential 12/07/20 7:55 AM
Trimming my position a little today. Cosa 12/01/20 1:52 PM
"There are the two cannabis-based medications licensed for john1311 11/30/20 9:11 PM
An article from a year and a half Tanis2476 11/30/20 12:03 PM
$MJNA vs $GWPH https://www.fool.com/investing/2019/04/03/better-buy-medical-mari BottomBounce 11/29/20 4:32 PM
Chugging along! Monsterous move up over the past Cosa 11/24/20 3:16 PM
"Institutional investors and hedge funds own 80.52% of john1311 11/20/20 2:04 AM
GW Pharmaceuticals plc (NASDAQ:GWPH) Shares Acquired by Raymond AllGold818 11/19/20 9:16 PM
Fung where ya been Cosa 11/17/20 3:14 PM
Your way up now! :) Cosa 11/17/20 3:13 PM
Still going up. What a nice run Cosa 11/17/20 3:10 PM
$gwph $118.8 ^ 1.08 (0.92%) Taurus69 11/15/20 3:11 PM
$gwph $117.41 ^ 2.77 (2.42%) Taurus69 11/09/20 4:20 PM
BREAKING NEWS: $GWPH Is Innovative Industrial Properties a whytestocks 11/07/20 12:15 PM
NEWS: $GWPH GW Pharmaceuticals PLC (GWPH) Q3 2020 whytestocks 11/03/20 7:19 PM
+20% on the day! Woohoo :) Cosa 11/03/20 3:13 PM
NEWS: $GWPH Investor Ideas Potcasts, Cannabis News and whytestocks 11/03/20 2:45 PM
GW Pharmaceuticals stock set to rally after Phase john1311 11/03/20 2:23 PM
Breaking News: $GWPH GW Pharmaceuticals Initiates Phase 3 whytestocks 11/03/20 2:00 PM
JUST IN: $GWPH How GW Pharmaceuticals Blew Away whytestocks 11/03/20 1:45 PM
Just In: $GWPH GW Pharmaceuticals Stock Pops As whytestocks 11/03/20 1:30 PM
Breaking News: $GWPH GW Pharmaceuticals plc Reports Third whytestocks 11/03/20 1:00 PM
Breaking News: $GWPH GW Pharmaceuticals Initiates Pivotal Phase whytestocks 11/03/20 12:45 PM
I don’t know how they did compared to Kim1111 11/03/20 8:40 AM
Likes Subject
Older

Older
BottomBounce
11/16/21 11:02 AM
Magnum7419
07/01/21 12:34 PM
BottomBounce
06/17/21 2:04 PM
BottomBounce
06/10/21 11:25 AM
john1311
05/12/21 10:46 AM
lesgetrich
05/06/21 10:56 AM
Taurus69
03/20/21 8:33 PM
@realToothFairy
02/26/21 9:52 PM
Taurus69
02/19/21 7:00 PM
john1311
02/16/21 7:14 AM
SkyPilotUSA
02/11/21 9:03 AM
BottomBounce
02/05/21 11:08 AM
Panzer
02/04/21 2:08 AM
Tanis2476
02/03/21 7:41 PM
nunaka
02/03/21 6:28 PM
Cosa
02/03/21 1:00 PM
Sooo Waht
02/03/21 11:09 AM
longboarder7892
02/03/21 10:24 AM
Tanis2476
02/03/21 9:27 AM
mkendra
02/03/21 7:56 AM
Taurus69
01/30/21 7:29 PM
BottomBounce
01/16/21 8:27 AM
john1311
01/11/21 7:38 AM
Taurus69
01/05/21 10:53 PM
Taurus69
12/12/20 6:52 PM
@realToothFairy
12/10/20 5:12 PM
Cbdpotential
12/07/20 7:55 AM
Cosa
12/01/20 1:52 PM
john1311
11/30/20 9:11 PM
Tanis2476
11/30/20 12:03 PM
BottomBounce
11/29/20 4:32 PM
Cosa
11/24/20 3:16 PM
john1311
11/20/20 2:04 AM
AllGold818
11/19/20 9:16 PM
Cosa
11/17/20 3:14 PM
Cosa
11/17/20 3:13 PM
Cosa
11/17/20 3:10 PM
Taurus69
11/15/20 3:11 PM
Taurus69
11/09/20 4:20 PM
whytestocks
11/07/20 12:15 PM
whytestocks
11/03/20 7:19 PM
Cosa
11/03/20 3:13 PM
whytestocks
11/03/20 2:45 PM
john1311
11/03/20 2:23 PM
whytestocks
11/03/20 2:00 PM
whytestocks
11/03/20 1:45 PM
whytestocks
11/03/20 1:30 PM
whytestocks
11/03/20 1:00 PM
whytestocks
11/03/20 12:45 PM
Kim1111
11/03/20 8:40 AM

GW Pharmaceuticals Plc ADS (GWPH)

Followers
259
Posters
547
Posts (Today)
0
Posts (Total)
5916
Created
04/18/13
Type
Free
Moderators

 
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex(R), which is approved for the treatment of spasticity due to multiple sclerosis in 25 countries. Sativex is also in Phase 3 clinical development as a potential treatment of pain in people with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW has a deep pipeline of additional cannabinoid product candidates, including Epidiolex which has received Orphan Drug Designation from the FDA for the treatment of Dravet and Lennox-Gastaut syndromes, severe, drug-resistant epilepsy syndromes. GW's product pipeline also includes compounds in Phase 1 and 2 clinical development for glioma, ulcerative colitis, type-2 diabetes, and schizophrenia. For further information, please visit www.gwpharm.com 
 


GWPH Analyst Stock Ratings:

Citigroup - Target Cut from $97 to $86 - 6/30/14

Morgan Stanley - Overweight - $103 - 5/19/14 (Restated) 4/22/14 (Initiated)

Bank of America - Buy - $110 - 3/11/14

Piper Jaffray - Overweight - $147 - 6/30/14


 
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
Upgrade to Real-Time
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
GWPH Latest News
More GWPH News
Most Liked Posts
(Last 30 Days)
New Post